Financhill
Back

Pliant Therapeutics Stock Predictions

Pliant Therapeutics Stock Forecast

  • Is Pliant Therapeutics Stock Undervalued?
    The current Pliant Therapeutics [PLRX] share price is $1.46. The Score for PLRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • PLRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Pliant Therapeutics Stock Go Up Next Year?

Data Unavailable

Pliant Therapeutics Stock Rating

Data Unavailable

Pliant Therapeutics Stock Price History

Is PLRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
pliantrx.com

52-Week Data

52-Week High:
16.52
52-Week Low:
1.10

Prediction Charts

Market Cap:
89.4M
Price in USD:
1.46
Volume:
758.2K
Beta:
1.49

Technical Analysis

SMA50:
2.63
SMA100:
7.76
SMA200:
10.29
52-Wk Change:
-88.65%

Stock Predictions

  • Is Pliant Therapeutics stock public?
    Yes, Pliant Therapeutics is a publicly traded company.
  • What is the Pliant Therapeutics stock quote today?
    The Pliant Therapeutics stock price is 1.46 USD today.
  • How to buy Pliant Therapeutics stock online?
    You can buy Pliant Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-31 1.43 1.35 1.43 1.33
Apr-1 1.30 1.37 1.41 1.24
Apr-2 1.36 1.41 1.46 1.32
Apr-3 1.34 1.31 1.35 1.28
Apr-4 1.28 1.34 1.35 1.24
Apr-7 1.29 1.25 1.36 1.21
Apr-8 1.30 1.23 1.31 1.20
Apr-9 1.26 1.31 1.34 1.10
Apr-10 1.30 1.26 1.30 1.23
Apr-11 1.25 1.34 1.34 1.23
Apr-14 1.37 1.42 1.44 1.31
Apr-15 1.42 1.46 1.46 1.37
Apr-16 1.43 1.44 1.47 1.40
Apr-17 1.43 1.46 1.51 1.41

Pliant Therapeutics Earnings

Data Unavailable

Pliant Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.19 per share, an increase this year of $1.27 per share, and a decrease next year of $0.37 per share.

* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.